Wed, Aug 20, 2014, 12:52 PM EDT - U.S. Markets close in 3 hrs 8 mins

Recent

% | $
Quotes you view appear here for quick access.

Idera Pharmaceuticals, Inc. Message Board

  • oilman_12345 oilman_12345 Apr 16, 2014 11:11 AM Flag

    im8400

    Idera Pharmaceuticals - A Buying Opportunity Following The Fade by EXPstocktrader

    April 16, 2014

    If you have been following Idera Pharmaceuticals (IDRA), you know that they have been ramping up as one of the most cutting edge companies in the field of discovery and development of its TLR Antagonists, as well as synthetic DNA- and RNA- based drug candidates which I believe could radically change gene therapies in medicine today.

    Abstract #2570 As Presented at AACR in San Diego, CA on April 7, 2014

    In my review, the preclinical data is quite impressive and almost certainly provides a strong rationale for the phased studies being performed by Idera in ABC-DLBCL and Waldenstrom Macroglobulinemia. We are of course in the early stages, but what is most exciting about this poster is the proof of concept in its TLR Antagonists that are being used in its... In vitro Studies in MYD88 L265P - Positive ABC-DLBCL Cell Lines.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IDRA
2.58+0.02(+0.78%)12:52 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.